Details
Product Name in the RMS: Xanthadu 0,02 mg/3 mg
MR Number: NL/H/2884/001
Date of outcome: 21.11.2013
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Abridged Initial Application Generic Chemical Substance Prescription Only |
Active Substances |
drospirenone 3 mg ethinyl estradiol 0,02 mg |
Form | Film coated tablet |
MA Holder in the RMS |
Laboratorios Liconsa, S.A. Gran Vía Carlos III, 98, 7th floor 08028 - Barcelona SPAIN |
RMS | Netherlands |
Date of last change | 29.07.2020 |
ATC-Code |
G03AA12 Drospirenone and estrogen |
CMS Country | Domestic Product Name |
---|---|
Czech Republic | Xanthadu 0.02 mg/3 mg, film-coated tablets |
Denmark | Xanthadu |
France | |
Greece | XANTHADU |
Poland | Axia Conti |
Romania | Xanthadu 3 mg/ 0.02 mg comprimate filmate |
Slovak Republic | Xanthadu |
United Kingdom |
Documents | |
---|---|
PAR: | NL_H_2884_001_PAR.pdf (15.01.2015) |
PARSummary: | NL_H_2884_001_PARSummary.pdf (15.01.2015) |
FinalSPC: | NL_H_2884_001_FinalSPC.pdf (11.09.2018) |
FinalPL: | NL_H_2884_001_FinalPL.pdf (24.06.2020) |
FinalLabelling: | NL_H_2884_001_FinalLabelling_1of6.pdf (03.07.2017) |
FinalLabelling: | NL_H_2884_001_FinalLabelling_2of6.pdf (03.07.2017) |
FinalLabelling: | NL_H_2884_001_FinalLabelling_3of6.pdf (03.07.2017) |
FinalLabelling: | NL_H_2884_001_FinalLabelling_4of6.pdf (03.07.2017) |
FinalLabelling: | NL_H_2884_001_FinalLabelling_5of6.pdf (03.07.2017) |
FinalLabelling: | NL_H_2884_001_FinalLabelling_6of6.pdf (03.07.2017) |